Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

Cardiovascular Diabetology
Dalia El-LebedyAsmaa M Mohammed

Abstract

Lipoprotein-related mechanisms have been associated with damage to the cardiovascular system in diabetic patients. Apolipoprotein E gene which affects the clearance of lipoproteins and consequently the lipid profile in our body is one of the most studied candidate genes and recently has been reported to be associated with T2DM and CAD. In this work, we studied the association of apoE gene polymorphism with T2DM and CVD and its effect on plasma lipids profile. Our study was conducted on 284 subjects categorized into 100 patients with T2DM, 100 patients with T2DM complicated with CVD and 84 normal control subjects. ApoE gene polymorphism was genotyped by real-time PCR using TaqMan(®) SNP Genotyping Assay. ApoE E3/E3 genotype was the most common in our subjects. The frequencies of E3/E4 genotype and ε4 allele were increased in both T2DM patients and CVD patients as compared with controls, but were significant only in CVD patients (p = 0.004 and 0.007, respectively). Diabetic patients who carried E3/E4 genotype were at 2.4-fold increased risk to develop CVD (95 % CI 1.14-5.19, P = 0.02) and the ε4 allele associated with 2.23-fold higher CVD risk (95 % CI 1.09-4.59, P = 0.02). After adjustment for other established risk factors, E3/...Continue Reading

References

Oct 10, 1992·Lancet·F M van Bockxmeer, C D Mamotte
Jan 15, 1993·The American Journal of Cardiology·J E EichnerJ D Neaton
Jun 8, 1999·The Journal of Clinical Investigation·C KnouffN Maeda
Apr 18, 2000·Diabetologia·C C HedrickA L Peters
Oct 3, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·G AttilaL Kayrin
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R W Mahley, S C Rall
Mar 8, 2002·American Journal of Epidemiology·June E EichnerBerrit C Stroehla
Jul 4, 2002·Current Medical Research and Opinion·Genovefa KolovouDennis V Cokkinos
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·Mariano SentíJaume Marrugat
Nov 17, 2004·Current Pharmaceutical Design·A J JenkinsR L Klein
Apr 4, 2006·Nature Reviews. Drug Discovery·Scott M Grundy
Nov 10, 2006·Annals of Human Biology·P P SinghS S Mastana
Jan 17, 2007·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A Mendes-LanaR N Freitas
Apr 1, 2008·Indian Journal of Medical Sciences·P P SinghS K Gaur
Apr 29, 2010·Current Atherosclerosis Reports·Godfrey S GetzCatherine A Reardon
Apr 24, 2012·Cardiovascular Diabetology·Rajesh ChaudharyCharn Sriratanasathavorn
Mar 2, 2013·Current Pharmaceutical Design·Teresa Vanessa FiorentinoFranco Folli
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jun 13, 2014·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Daniel Lorber
Sep 28, 2015·Clinical and Experimental Medicine·Dil AfrozeAsrar Ahmad

❮ Previous
Next ❯

Citations

Feb 20, 2016·Cardiovascular Diabetology·Dalia El-LebedyAsmaa M Mohammed
Oct 16, 2016·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Li-Jung ChenPo-Wen Ku
Dec 31, 2016·Journal of Alzheimer's Disease : JAD·Anne Katrine BerglandHogne Soennesyn
Jul 15, 2017·Annals of Human Biology·Grażyna AdlerAlmira Hadzovic-Dzuvo
Jun 29, 2017·Journal of Alzheimer's Disease : JAD·Prita R AsihRalph N Martins
Feb 2, 2018·Frontiers in Endocrinology·Salvatore De RosaDaniela P Foti
Jan 30, 2018·Nature Reviews. Neurology·Steven E ArnoldDavid M Nathan
Aug 9, 2016·Journal of Molecular Neuroscience : MN·Amy L HeffernanBlaine R Roberts
Sep 29, 2020·Frontiers in Neuroscience·María Teresa Flores-DorantesRuth Gutiérrez-Aguilar
May 2, 2018·Lipids in Health and Disease·Israa M ShatwanKarani S Vimaleswaran
Jul 29, 2017·International Journal of Endocrinology and Metabolism·Mehri MoghadasiMohammad Esmaeil Motlagh
Dec 28, 2018·International Journal of Molecular Sciences·Nahdia S Jones, G William Rebeck
Apr 29, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Hua PanMuchao Wu
Apr 16, 2020·Alzheimer's Research & Therapy·Matthieu LilamandClaire Paquet
Apr 3, 2019·Experimental and Therapeutic Medicine·Shou-Feng ZhaoGuang-Jun Shi
Sep 13, 2018·International Journal of Environmental Research and Public Health·Gabriela P F ArrifanoMaria Elena Crespo-Lopez
Feb 18, 2021·Genetic Testing and Molecular Biomarkers·Chang GaoGangMing Shu
Feb 8, 2020·Neurobiology of Disease·P M Sullivan
Feb 23, 2020·Neurobiology of Disease·Cutler T LewandowskiMary Jo LaDu
Jul 25, 2021·Nature Communications·Ganna LeonenkoValentina Escott-Price
Jul 27, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chung-Lin JiangFu-Jung Lin
Aug 19, 2021·Alzheimer's Research & Therapy·Valentina Escott-Price, Karl Michael Schmidt

❮ Previous
Next ❯

Methods Mentioned

BETA
Genotyping
PCR

Software Mentioned

SPSS

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.